# A Clinical Study of AK0610

> **NCT06996704** · PHASE1 · RECRUITING · sponsor: **Shanghai Ark Biopharmaceutical Co., Ltd.** · enrollment: 136 (estimated)

## Conditions studied

- Healthy Volunteer Study

## Interventions

- **DRUG:** AK0610 Injection solution
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06996704
- **Lead sponsor:** Shanghai Ark Biopharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-29
- **Primary completion:** 2025-06
- **Final completion:** 2025-09
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2025-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06996704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06996704, "A Clinical Study of AK0610". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06996704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*